Skip to main content

Peer Review reports

From: Efficacy of selenium supplementation for mild-to-moderate Graves’ ophthalmopathy in a selenium-sufficient area (SeGOSS trial): study protocol for a phase III, multicenter, open-label, randomized, controlled intervention trial

Original Submission
19 Dec 2022 Submitted Original manuscript
4 Jan 2023 Reviewed Reviewer Report - Sepide Amini
10 Jan 2023 Reviewed Reviewer Report - Ramesh Allipour-Birgani
13 Jan 2023 Reviewed Reviewer Report - Alexander Gough
15 Feb 2023 Author responded Author comments - Chae Won Chung
Resubmission - Version 2
15 Feb 2023 Submitted Manuscript version 2
16 Feb 2023 Reviewed Reviewer Report - Sepide Amini
21 Feb 2023 Reviewed Reviewer Report - Alexander Gough
21 Feb 2023 Author responded Author comments - Chae Won Chung
Resubmission - Version 3
21 Feb 2023 Submitted Manuscript version 3
27 Feb 2023 Reviewed Reviewer Report - Alexander Gough
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
28 Mar 2023 Editorially accepted
14 Apr 2023 Article published 10.1186/s13063-023-07282-4

You can find further information about peer review here.

Back to article page